KLBF:IDX
Kalbe Farma Tbk PT
IDR ७८५.००
arrow_upward
+०.६४%(+५.००) 1D
अक्टोबर १५, १०:०४:५८ GMT+७ · IDR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KLBF...
Open
IDR ७८०
High
IDR ७९०
Low
IDR ७७५
Mkt. cap
३.७० शंख
Avg. vol.
६.३६ करोड
Volume
५१.०३ लाख
Dividend
२.५५%
Quarterly dividend
IDR ५
Ex-dividend date
२०२६ जुन ४
P/E ratio
९.८७
52-wk high
IDR १,३४५
52-wk low
IDR ६३०
EPS
IDR ८०
Shares outstanding
४६.८१ अरब
No. of employees
१३ हजार
Open
IDR ७८०
High
IDR ७९०
Low
IDR ७७५
Mkt. cap
३.७० शंख
Avg. vol.
६.३६ करोड
Volume
५१.०३ लाख
Dividend
२.५५%
Quarterly dividend
IDR ५
Ex-dividend date
२०२६ जुन ४
P/E ratio
९.८७
52-wk high
IDR १,३४५
52-wk low
IDR ६३०
EPS
IDR ८०
Shares outstanding
४६.८१ अरब
No. of employees
१३ हजार
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
·
४६ मिनेट पहिले
FILE PHOTO: SK Hynix at the Nasdaq market in New York
Simply Wall Street
·
१५ मिनेट पहिले
Raised Guidance Could Change The Case For Nextpower Stock
Yardeni QuickTakes
·
२२ मिनेट पहिले
Continue To Proceed With Caution
Yahoo Finance
·
६ घण्टा पहिले
You’d Be Foolish to Ignore 5% Returns on Bonds, Especially as Blue-Chip Stocks Fail to Deliver
Profile
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
About Kalbe Farma Tbk PT